Colorectal Cancer Clinical Trial
Official title:
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
The goal of this study is to understand factors which may influence risk for colorectal and other cancers in families. These factors include genetic variability, in combination with diet and lifestyle. In order to achieve these goals, we need to contact as many eligible participants as possible.
If you agree to take part in this study, you will have a single sample (8-10 teaspoons) of
blood collected, depending upon current health status. The blood will be drawn at MD
Anderson. If you cannot come to the clinic, a blood drawing kit will be sent to the your
home, which will include instructions and a postage-paid return express mail envelope.
Phlebotomy charges connected to this study will be paid by the study. The blood sample will
be sent to a research laboratory at MD Anderson for analyses. If you are unwilling or unable
to give a blood sample, you can give a saliva sample instead. In this case, a kit will be
mailed to you with instructions for obtaining the saliva sample. A prepaid envelope will be
included for its return. Participants who previously participated in Protocol PA11-0567 and
provided a blood sample do not need to provide another blood sample. The previously stored
blood sample collected by Protocol PA11-0567 may be used.
You will be asked to answer a series of questions. These questions will ask about foods eaten
either one year ago or one year before the first diagnosis of cancer. There will also be
questions about cooking methods as well as overall health, and vitamin and medication use.
Some of the questions are personal, but all answers will be kept strictly private.
The questionnaire will be sent to your home via U.S. or express mail. It may take several
hours to complete the survey, but there is no time limit on its completion. There are no
right or wrong answers to the questions. A postage-paid return envelope will be provided for
the return of the questionnaire.
Solid tumor material and colonoscopy specimens of normal tissue will be collected from
participants requiring either colonoscopy or surgery for routine clinical reasons. The tumor
fragments will be collected from specimens. Tissue required for a clinical pathology
diagnosis will not be used for research purposes.
This is an investigational study. About 2,000 patients and family members will take part in
this study. All will be enrolled at MD Anderson.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |